Navigation Links
Study: Mega Vitamins Won't Help After Heart Attack, Chelation Treatment Might
Date:3/10/2013

By E.J. Mundell
HealthDay Reporter

SUNDAY, March 10 (HealthDay News) -- There's mixed news from a much-anticipated clinical trial for people who've suffered a heart attack: While a study found that daily high doses of vitamins and minerals did nothing to improve patient outcomes, there was a hint that controversial "chelation" therapy might.

Still, the lead researcher said he's not ready to recommend chelation therapy, in which doctors give patients high-dose vitamins along with special infusions that seek to leach heavy metals from the body.

"These findings should stimulate further research, but are not by themselves sufficient to recommend the routine use of chelation therapy and high-dose vitamins in most patients," said Dr. Gervasio Lamas, chief of the Columbia University Division of Cardiology at Mount Sinai Medical Center, in Miami Beach, Fla.

The trial, which was funded by the U.S. National Institutes of Health, looked at whether chelation therapy might help patients who'd suffered a heart attack. The findings were presented Sunday at the American College of Cardiology (ACC) annual meeting, in San Francisco.

The expensive treatment, which involves dozens of arduous infusions conducted over a period of years, has been offered by certain clinics for decades but has yet to gain U.S. Food and Drug administration approval for heart patients.

However, its reputation got a boost in November when preliminary results from the same trial were presented at the annual meeting of the American Heart Association. Those results did show a modest benefit from chelation therapy for some patients.

The trial involved more than 1,700 patients from the United States and Canada who had suffered a prior heart attack. Most were already taking standard therapies such as daily aspirin, cholesterol-lowering statins or blood pressure medications.

Because chelation therapy also involves daily high-dose vitami
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Study: Diabetic medication may protect patients from developing heart failure
2. Doctors Health Press Reports on German Study: Only 20% of Patients Get Colonoscopies, Important in Preventing and Diagnosing Colon Cancer
3. Bel Marra Health Reports on a New Study: Parents are Much More Likely to Experience Symptoms of Depression and Anxiety
4. Study: HPV Genital Warts is Most Common Sexually Transmitted Infection in U.S. Military, polyDNA Recommends Gene-Eden-VIR Against the HPV Infection
5. Study: Computerized reminders significantly improve HIV care in resource-limited setting
6. New gender benchmarking study: Brazil succeeding in providing a positive STI environment for women
7. Bel Marra Health Reports on a New Study: Software Originally Used for Star Gazing Now Being Used to Analyze Breast Cancer Tissue
8. Study: Same-sex cohabitors less healthy than those in heterosexual marriages
9. Doctors Health Press Reports on Study: Heart-Healthy Linoleic Acid Levels Decrease with Age
10. Study: Electronic Prescribing Cuts Medication Errors
11. Regenstrief study: Informatics tools underutilized in prevention of hospital-acquired infection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study: Mega Vitamins Won't Help After Heart Attack, Chelation Treatment Might
(Date:2/28/2015)... 28, 2015 For those people who ... the Mesothelioma Applied Research Foundation (Meso Foundation) ... March 3, starting at 9:30 AM. , The live ... The broadcast can be accessed through any browser on ... , The Symposium is a unique event that covers ...
(Date:2/28/2015)... Louis, MO (PRWEB) February 28, 2015 ... leading provider of outsourced sales, marketing and supply ... their client, BIOTA Botanicals, is bringing its award ... Celebrated worldwide, BIOTA Botanicals’ products are specifically created ... herbal care experts, BIOTA is committed to marrying ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 ... discuss federal testosterone lawsuits that have been filed by ... for the second week in March, the Firm notes. ... Court’s website, parties involved in the federal litigation will ... address matters related to prescription therapy treatments designed to ...
(Date:2/28/2015)... 28, 2015 On Thursday, February 26th, Forbes ... Easy For Scammers To Steal Your Data , which stresses ... hands on a DIY phishing kit, or any kind of ... on another important point about how everyone’s cyber security is ... implemented, “like compromising legitimate content management systems or blogs in ...
(Date:2/28/2015)... Developers of FCPX plugins and theme templates ... Final Cut Pro X entitled FCPX Overlay Chromatic Grunge 6K ... total control over 6k lens dirt overlays inside Final Cut ... “FCPX Overlay Chromatic was professionally designed to add level of ... Overlay Chromatic Grunge 6K is a resourceful tool from Pixel ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2
... Inc. announced today an initiation of Phase I clinical ... of Alzheimer,s disease. The results of Phase I studies ... on these and other results, Avineuro Pharmaceuticals, Inc. plans ... Q2 2009. Avineuro Pharmaceuticals, Inc. presented at the 9th ...
... Show U.S. Rx Abandonment Rate Up 34 Percent Since ... 2008BRIDGEWATER, N.J., April 7 /PRNewswire/ ... of information and business intelligence for students, professionals and ... pharmaceutical industry, today released its annual analysis of the ...
... services , ... Dallas, TX (Vocus) April 7, 2009 ... Blue Island, Illinois has selected Broadlane as the exclusive provider of ... approximate $25 million in annual spend., , , , ,MetroSouth Medical ...
... to compliment the Small Business Administration,s recent announcement of $730 million ... banks and make it easier for entrepreneurs and start-ups to get ... ... (PRWEB) April 7, 2009 -- Health Career Agents announces SBA Pre-Approval ...
... vital for charities - Charity websites help raise ... networks - Women in Need helps women from ... illness, rape & abuseHARTFORD, England, April 7 ... from Hartford, Cheshire, has recently completed a newly ...
... Intervet/Schering-Plough Animal Health today announces that the ... testing goes to Dr. Ivo Claassen for a ... Veterinary Institute (CVI), Lelystad (the Netherlands). The announcement ... an independent expert jury panel and Professor of ...
Cached Medicine News:Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 2Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 3Health News:2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics 4Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 2Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 3Health News:MetroSouth Medical Center Selects Broadlane to Provide Comprehensive Supply Chain Services 4Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 2Health News:Health Career Agents Announces SBA Pre-Approval Program to Launch a Healthcare Recruiting Business 3Health News:Local Web Design Agency Launches Leprosy Charity Website for Women in Need 2Health News:Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay 2Health News:Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay 3
(Date:2/27/2015)... Feb. 27, 2015 Pharmaceutical and biotech marketers ... products for the same indication. This can be a ... to prevent one of their brands from gaining market ... to recent research by benchmarking firm, Best Practices, LLC, ... brands rather than together as part of a franchise. ...
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... published in the Proceedings of the National ... showed when ibrutinib (IMBRUVICA ® ) was combined ... of tumor growth was enhanced suggesting a greater ... cancers and solid tumors with the combination. IMBRUVICA ...
(Date:2/27/2015)... Feb. 27, 2015 Securities lawyers at ... Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ) in ... Concerned SLXP investors are encouraged to contact attorney Hamilton ... The investigation focuses upon the shareholder value of the ... would receive only $158.00 per share in cash. At ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9
... BIRMINGHAM, Ala. , Feb. 4 BioCryst Pharmaceuticals, ... the fourth quarter and year ended December 31, 2009 ... strides towards the goal of building an enduring and successful ... Chief Executive Officer of BioCryst Pharmaceuticals.  "Peramivir has delivered the ...
... REDWOOD CITY, Calif. , Feb. 3 Genomic Health, ... ended December 31, 2009 , which included 35 percent revenue growth ... revenue for the fourth quarter of 2009 increased to $39.6 million ... 2008.  Product revenue from the Onco type DX® breast cancer test ...
Cached Medicine Technology:BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 2BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 3BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 4BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 5BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 6BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 7BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 8BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 9BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update 10Genomic Health Announces Year-End 2009 Financial Results 2Genomic Health Announces Year-End 2009 Financial Results 3Genomic Health Announces Year-End 2009 Financial Results 4Genomic Health Announces Year-End 2009 Financial Results 5Genomic Health Announces Year-End 2009 Financial Results 6Genomic Health Announces Year-End 2009 Financial Results 7Genomic Health Announces Year-End 2009 Financial Results 8Genomic Health Announces Year-End 2009 Financial Results 9Genomic Health Announces Year-End 2009 Financial Results 10Genomic Health Announces Year-End 2009 Financial Results 11Genomic Health Announces Year-End 2009 Financial Results 12
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: